Literature DB >> 27623813

Transdifferentiation Requires iNOS Activation: Role of RING1A S-Nitrosylation.

Shu Meng1, Gang Zhou1, Qilin Gu1, Palas K Chanda1, Frank Ospino1, John P Cooke2.   

Abstract

RATIONALE: We have previously shown that innate immunity is necessary for transdifferentiation of fibroblasts to endothelial cells. A major signaling molecule involved in innate immunity is inducible nitric oxide synthase (iNOS). Accordingly, we hypothesized that iNOS-generated nitric oxide (NO) might enhance transdifferentiation.
OBJECTIVE: To elucidate the role of NO in epigenetic plasticity during transdifferentiation. METHODS AND
RESULTS: We exposed the BJ fibroblasts to transdifferentiation formulation that included endothelial growth factors and innate immune activator polyinosinic:polycytidylic acid to induce endothelial cells. Generation of transdifferentiated endothelial cells was associated with iNOS expression and NO elaboration. In the absence of polyinosinic:polycytidylic acid, or in the presence of antagonists of NFκB (nuclear factor kappa B) or iNOS activity, NO synthesis and induce endothelial cell generation was reduced. Furthermore, genetic knockout (in murine embryonic fibroblasts) or siRNA knockdown (in BJ fibroblasts) of iNOS nearly abolished transdifferentiation, an effect that could be reversed by iNOS overexpression. Notably, polyinosinic:polycytidylic acid induced nuclear localization of iNOS, and its binding to, and nitrosylation of, the epigenetic modifier ring finger protein 1A (RING1A) as assessed by immunostaining, Co-IP, and mass spectrometry. Nitrosylation of RING1A reduced its binding to chromatin and reduced global levels of repressive histone marker H3K27 trimethylation. Overexpression of a mutant form of RING1A (C398A) lacking the nitrosylation site almost abrogated transdifferentiation.
CONCLUSIONS: Overall, our data indicate that during transdifferentiation, innate immune activation increases iNOS generation of NO to S-nitrosylate RING1A, a key member of the polycomb repressive complex. Nitrosylation of RING1A reduces its binding to chromatin and decreases H3K27 trimethylation level. The release of epigenetic repression by nitrosylation of RING1A is critical for effective transdifferentiation.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  chromatin; endothelial cell; epigenetic repression; innate immunity; mass spectrometry

Mesh:

Substances:

Year:  2016        PMID: 27623813      PMCID: PMC5065398          DOI: 10.1161/CIRCRESAHA.116.308263

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

Review 1.  S-nitrosylation: physiological regulation of NF-kappaB.

Authors:  Harvey E Marshall; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

2.  Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation.

Authors:  Paschalis-Thomas Doulias; Jennifer L Greene; Todd M Greco; Margarita Tenopoulou; Steve H Seeholzer; Roland L Dunbrack; Harry Ischiropoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

3.  Plasticity of the differentiated state.

Authors:  H M Blau; G K Pavlath; E C Hardeman; C P Chiu; L Silberstein; S G Webster; S C Miller; C Webster
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

Review 4.  Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide.

Authors:  Andrea Predonzani; Bianca Calì; Andrielly Hr Agnellini; Barbara Molon
Journal:  World J Exp Med       Date:  2015-05-20

Review 5.  Protein S-nitrosylation: purview and parameters.

Authors:  Douglas T Hess; Akio Matsumoto; Sung-Oog Kim; Harvey E Marshall; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

6.  Evidence for a functional nitric oxide synthase system in brown adipocyte nucleus.

Authors:  Antonio Giordano; Cristina Tonello; Alessandra Bulbarelli; Valeria Cozzi; Saverio Cinti; Michele O Carruba; Enzo Nisoli
Journal:  FEBS Lett       Date:  2002-03-13       Impact factor: 4.124

Review 7.  Chromatin modifiers and remodellers: regulators of cellular differentiation.

Authors:  Taiping Chen; Sharon Y R Dent
Journal:  Nat Rev Genet       Date:  2013-12-24       Impact factor: 53.242

Review 8.  The role of nitric oxide in cancer.

Authors:  Weiming Xu; Li Zhi Liu; Marilena Loizidou; Mohamed Ahmed; Ian G Charles
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

9.  S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons.

Authors:  Alexi Nott; P Marc Watson; James D Robinson; Luca Crepaldi; Antonella Riccio
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

Review 10.  iNOS-selective inhibitors for cancer prevention: promise and progress.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  Future Med Chem       Date:  2012-11       Impact factor: 3.808

View more
  17 in total

Review 1.  Inflammation and Its Role in Regeneration and Repair.

Authors:  John P Cooke
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

Review 2.  Transflammation: Innate immune signaling in nuclear reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Adv Drug Deliv Rev       Date:  2017-09-13       Impact factor: 15.470

3.  Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage.

Authors:  Li Lai; Erin Reineke; Dale J Hamilton; John P Cooke
Journal:  Circulation       Date:  2019-01-02       Impact factor: 29.690

4.  Reservoir of Fibroblasts Promotes Recovery From Limb Ischemia.

Authors:  Shu Meng; Jie Lv; Palas K Chanda; Iris Owusu; Kaifu Chen; John P Cooke
Journal:  Circulation       Date:  2020-08-21       Impact factor: 29.690

Review 5.  Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Antioxid Redox Signal       Date:  2018-04-26       Impact factor: 8.401

6.  Nuclear S-Nitrosylation Defines an Optimal Zone for Inducing Pluripotency.

Authors:  Palas K Chanda; Shu Meng; Jieun Lee; Honchiu E Leung; Kaifu Chen; John P Cooke
Journal:  Circulation       Date:  2019-08-15       Impact factor: 29.690

Review 7.  Vascular Regeneration in Peripheral Artery Disease.

Authors:  John P Cooke; Shu Meng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-21       Impact factor: 8.311

8.  TBX20 Regulates Angiogenesis Through the Prokineticin 2-Prokineticin Receptor 1 Pathway.

Authors:  Shu Meng; Qilin Gu; Xiaojie Yang; Jie Lv; Iris Owusu; Gianfranco Matrone; Kaifu Chen; John P Cooke; Longhou Fang
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

Review 9.  Biomimetic and immunomodulatory therapeutics as an alternative to natural exosomes for vascular and cardiac applications.

Authors:  Ramiro A Villarreal-Leal; John P Cooke; Bruna Corradetti
Journal:  Nanomedicine       Date:  2021-03-24       Impact factor: 6.096

Review 10.  New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease.

Authors:  Brian H Annex; John P Cooke
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.